Epigenetics has flourished to become one of the most revolutionary areas of science over the past decade. Also, advances in the understanding of epigenetic processes, have led to a burst in interest in this area as a potential source of new targets for the discovery of medicines.
While the promise of epigenetics is significant, it also presents some interesting challenges like pathways and mechanisms underlying epigenetics, using right screening platforms, bottlenecks in translational and clinical phase, collating epigenetics data with proper analysis and finding the right biomarkers.
At the 2nd Annual Epigenetics Discovery Congress, which will be held on 8-9 September, 2016 in London, UK, where researchers, academics and industry professionals working in epigenetic research can avail an opportunity to explore the potential of epigenetics to contribute towards novel and existing therapeutics, current progress and trends in the inclusion of epigenetics in drug discovery and development.
Along with advanced technologies and solution, the conference will also focus on highlighting some of the emerging themes in terms of drug discovery approach with respect to evolving targets, inhibitors, biomarkers and clinical success of epigenetics across various diseases. For more information please email: [email protected]
URL:
http://www.mnmconferences.com/2nd-Annual-Epigenetics-Discovery-Congress
Contact:
Email: [email protected]
Tel: +91 20 6708 0270 (ASIA)